EMEA-001999-PIP02-17-M01 - paediatric investigation plan

Cenicriviroc

Key facts

• Active Substance:
  Cenicriviroc
• Therapeutic area:
  Gastroentology-Hepatology
• Decision number:
  P/0356/2020
• PIP number:
  EMEA-001999-PIP02-17-M01
• Pharmaceutical form(s):
  • Age-appropriate oral liquid dosage form
  • Film-coated tablet
• Condition(s) / indication(s):
  Treatment of non-alcoholic steatohepatitis (NASH)
• Route(s) of administration:
  Oral use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  09/09/2020

Decision

P/0356/2020 : EMA decision of 9 September 2020 on the acceptance of a modification of an agreed paediatric investigation plan for cenicriviroc (EMEA-001999-PIP02-17-M01)

AdoptedReference Number: EMA/415149/2020